Marijuana Reclassified as Less Dangerous by Trump Administration

In a significant policy change, the Trump administration has reclassified marijuana, moving it to a less dangerous category of drugs. This decision places marijuana on the same level as medications like Tylenol with codeine, which are considered to have a lower potential for abuse.

This reclassification aims to make it easier for researchers to study cannabis and explore its medical benefits. Supporters of the change believe that it will help increase access to marijuana for both therapeutic and recreational use.

Implications of the New Classification

Previously, marijuana was classified as a Schedule I drug, which meant it was viewed as having no accepted medical use and a high potential for abuse. The new classification could lead to more funding for research and could also influence how states regulate cannabis.

Experts suggest that this change might encourage more medical professionals to consider cannabis as a treatment option for various conditions. As more studies emerge, the understanding of marijuana’s effects could evolve, potentially leading to broader acceptance and legalization in different states.

With this reclassification, the administration hopes to balance public health concerns with the growing demand for cannabis products. The move reflects shifting attitudes towards marijuana in the U.S., where many states have already legalized it for medical and recreational use.

The new policy is part of a larger trend of reconsidering drug classifications and addressing issues related to drug use and addiction. Advocates for drug reform see this as a step in the right direction, while opponents worry about the implications of increased access to marijuana.

Image: BBC — source